Emergent Biosolutions, Inc. (EBS)
NYSE: EBS · Pharmaceutical Preparations · Gaithersburg, MD · filing with the SEC since 2006
Grade4.6
◀ Past 4.6● Present 5.4▶ Future 3.5
Filings
361 filings since 2017 beside 468 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026Due nextAccelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 33 days after the quarter ended. The proxy statement was last filed Mar 20, 2026.
Filings a yearinsider forms included
57947766101958787
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Oct 16, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Nov 24, 2023.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Nov 16, 2023.SEC letters: 4 in the last 36 months, the newest Aug 13, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 2, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 5, 2026
8-K items 2.02, 2.05, 5.02, 7.01, 9.01
Results released; Exit or restructuring costs; Officer or director change; Investor disclosure (Regulation FD) · Current report
Jun 29, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jun 26, 2026
Apr 30, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Apr 17, 2026
8-K items 1.01, 1.02, 3.02, 7.01, 9.01
Major agreement signed; Major agreement ended; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Apr 16, 2026
Mar 3, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Feb 25, 2026
Feb 26, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Nov 12, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Nov 7, 2025
Oct 29, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Sep 11, 2025
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Sep 5, 2025
40 of 361 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.